Superiority of Escitalopram over Paroxetine in the treatment of Major Depressive Disorder (MDD)

被引：0
|
作者：
Kasper, S. [1 ]
Baldwin, D. [2 ]
Boulenger, J. P. [3 ,4 ]
机构：
[1] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
[2] Univ Southampton, Clin Neurosci Div, Southampton, Hants, England
[3] CHU Montpellier, Montpellier, France
[4] Univ Dept Adult Psychiat, INSERM, U 888, Montpellier, France
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2008年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [1] Escitalopram and paroxetine in the short and long-term treatment of major depressive disorder (MDD)
    Baldwin, D
    Hindmarch, I
    Huusom, AKT
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S168 - S169
  • [2] Comparison of escitalopram and paroxetine in the treatment of major depressive disorder
    Lin, Huang-Li
    Hsu, Ya-Ting
    Liu, Chia-Yih
    Chen, Chia-Hui
    Hsiao, Mei-Chun
    Liu, Yu-Li
    Shen, Winston W.
    Hsiao, Chin-Fu
    Liu, Shen-Ing
    Chang, Liang-Huey
    Tang, Hwa-Sheng
    Lai, Hsiang-Ling
    Lin, Pei-Sheng
    Lin, Keh-Ming
    Tsou, Hsiao-Hui
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (06) : 339 - 345
  • [3] Pooled analysis: 2 randomised clinical trials confirms superiority of escitalopram over paroxetine in treatment of major depressive disorder
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S297 - S298
  • [4] Pooled analysis of two randomised clinical trials of escitalopram and paroxetine fit the treatment of major depressive disorder (MDD)
    Kasper, S.
    Baldwin, D.
    Boulenger, J. -P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 193 - 193
  • [5] A pharmacoeconomic comparison of escitalopram and duloxetine in treatment of major depressive disorder (MDD) in the United Kingdom
    Wade, A. G.
    Fernandez, J. L.
    Francois, C.
    Hansen, K.
    Despiegel, N.
    Danchenko, N.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A306 - A306
  • [6] Superiority of escitalopram to paroxetine in the treatment of depression
    Kasper, Siegfried
    Baldwin, David S.
    Lonn, Sara Larsson
    Boulenger, Jean-Philippe
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (04) : 229 - 237
  • [7] ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Nogas, G.
    Garbacka, M.
    Obrzut, G.
    Pieniazek, I
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A114 - A114
  • [8] Long-term treatment of severe major depression (MDD) with escitalopram or paroxetine
    Boulenger, J. P.
    Huusom, A. K. T.
    Weiller, E.
    Florea, I.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S229 - S229
  • [9] COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Malysiak, S.
    Rowinska, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A107 - A107
  • [10] ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD) - BUDGET IMPACT ANALYSIS
    Walczak, J.
    Nogas, G.
    Garbacka, M.
    Obrzut, G.
    Pieniazek, I
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A109 - A109
12345